EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes

Xiaopu Wang, Junyu Pei iD, Keyang Zheng, Maojun Liu iD, Xinqun Hu iD

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16112 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Xiaopu Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Libin Cardiovascular Institute of Alberta, University of Calgary, Health Sciences Centre, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Antihypertensive Agents, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Angiopathies. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The efficacy of intensive blood pressure (BP) control remains controversial, and the variability of HbA1c was a risk factor for macrovascular events in patients with type 2 diabetes. We investigated whether the HbA1c variability modifies the efficacy of intensive BP control.

Methods

Data from the Action to Control Cardiovascular Risk in Diabetes Blood Pressure (ACCORD‐BP) trial was utilized. K‐means clustering was used to cluster patients into three groups based on the HbA1c variability score and baseline HbA1c values. Cox proportional hazard models and generalized linear models were used to measure the subgroup differences in intensive BP control treatment effects. The primary outcome was a composite of nonfatal myocardial infarction (MI), stroke, or death from cardiovascular causes.

Results

In patients with low HbA1c variability rather than medium or high HbA1c variability, intensive BP control reduced the risk of the primary outcome on a relative scale (HR 0.60, 95%CI 0.40–0.90, p interaction was 0.03), non‐fatal MI (HR 0.61, 95% CI 0.37–1.00, p interaction was 0.04) and stroke (HR 0.19, 95%CI 0.05–0.64, p interaction was 0.02) or absolute scale. Regardless of the variability group, intensive BP control did not reduce the risk of cardiovascular or all‐cause mortality ( p interaction >0.05) both on relative and absolute risk scales.

Conclusion

HbA1c variability had effect on the efficacy of intensive BP control and intensive BP control brought a significant macrovascular benefit in patients with type 2 diabetes and low HbA1c variability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsCardiovascular DiseasesDiabetes Mellitus, Type 2Diabetic AngiopathiesGlycated HemoglobinHypertensionAgedFemaleHumansMaleMiddle AgedBlood PressureMyocardial InfarctionProportional Hazards ModelsRisk FactorsStrokeTreatment Outcome

Stichwörter der Autor:innen

HbA1c variabilityintensive blood pressure controlmachine learning algorithmsmacrovascular outcomesstroke

Substanzen

Antihypertensive AgentsGlycated Hemoglobinhemoglobin A1c protein, human

Autor:innen und Institutionen

  • Libin Cardiovascular Institute of Alberta, University of Calgary, Health Sciences Centre, Calgary, Alberta, Canada.
  • Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
  • Department of Cardiovascular Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Junyu Pei, Maojun Liu, Xinqun Hu

Zitieren

APA

Wang, X., Pei, J., Zheng, K., Liu, M., & Hu, X. (2025). The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16112

Vancouver

Wang X, Pei J, Zheng K, Liu M, Hu X. The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16112

BibTeX
@article{Wang2025,
  author = {Wang, Xiaopu and Pei, Junyu and Zheng, Keyang and Liu, Maojun and Hu, Xinqun},
  title = {The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16112}
}
Kostenlos starten →